You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 28, 2026

Claims for Patent: 6,649,187


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,649,187
Title:Use of polyalkylamine polymers in controlled release devices
Abstract:The invention provides a method and device for administering an amine drug, such as [S-(R,S)]-2-[4-[[(4-methyl)piperazin-1-yl]carbonyl]phenoxy]-3,3-diethyl-N-[1-(3,4-methylenedioxyphenyl)butyl]-4-oxo-1-azetidinecarboxamide), in a sustained release dosage form. The invention includes a pharmaceutical composition and dosage form containing a polyalkylamine polymer and an amine drug. The polyalkylamine polymer is a hydrogel that forms hydrated particles when exposed to an aqueous environment. When mixed with the amine drug in the core of a coated tablet, the polyalkylamine polymer controls the release of the amine drug into an aqueous environment of use. The hydrated particles of the polymer together with the amine drug are released from the tablet core through plural apertures in the surrounding coat.
Inventor(s):Munir A. Hussain, Arnold J. Repta
Assignee: Bristol Myers Squibb Pharma Co
Application Number:US10/074,385

Details for Patent 6,649,187

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Zenpep, Llc ZENPEP pancrelipase Capsule, Delayed Release 022210 August 27, 2009 6,649,187 2022-02-12
Zenpep, Llc ZENPEP pancrelipase Capsule, Delayed Release 022210 June 15, 2011 6,649,187 2022-02-12
Zenpep, Llc ZENPEP pancrelipase Capsule, Delayed Release 022210 July 13, 2011 6,649,187 2022-02-12
Zenpep, Llc ZENPEP pancrelipase Capsule, Delayed Release 022210 March 25, 2014 6,649,187 2022-02-12
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.